ACHIEVE LIFE SCIENCES

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities

30 Jun 2025 16:52:40 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

26 Jun 2025 20:43:33 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Proposed Underwritten Public Offering

26 Jun 2025 13:03:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

26 Jun 2025 13:02:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation

26 Jun 2025 13:01:45 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

28 May 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake

20 May 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program

13 May 2025 04:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

06 May 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

21 Apr 2025 08:19:48 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

11 Mar 2025 04:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

07 Mar 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025

06 Mar 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference

11 Feb 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

10 Feb 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

10 Jan 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission

07 Jan 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

06 Jan 2025 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

09 Dec 2024 05:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

03 Dec 2024 05:30:00 By Nasdaq GlobeNewswire